1. Home
  2. IBRX vs TOWN Comparison

IBRX vs TOWN Comparison

Compare IBRX & TOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$2.32

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo TowneBank

TOWN

TowneBank

HOLD

Current Price

$33.54

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
TOWN
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
IBRX
TOWN
Price
$2.32
$33.54
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$9.83
$41.00
AVG Volume (30 Days)
9.5M
270.4K
Earning Date
11-04-2025
10-22-2025
Dividend Yield
N/A
3.22%
EPS Growth
N/A
11.95
EPS
N/A
2.23
Revenue
$82,555,000.00
$766,599,000.00
Revenue This Year
$629.94
$23.63
Revenue Next Year
$109.91
$29.20
P/E Ratio
N/A
$15.03
Revenue Growth
1025.95
14.10
52 Week Low
$1.83
$29.43
52 Week High
$5.16
$38.28

Technical Indicators

Market Signals
Indicator
IBRX
TOWN
Relative Strength Index (RSI) 58.44 54.99
Support Level $2.05 $31.97
Resistance Level $2.18 $34.06
Average True Range (ATR) 0.13 0.68
MACD 0.03 0.17
Stochastic Oscillator 83.00 79.72

Price Performance

Historical Comparison
IBRX
TOWN

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About TOWN TowneBank

Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.

Share on Social Networks: